Clinical Trial

To Evaluate the Effectiveness and Safety of Single-port Robotic-assisted Subcutaneous Gland Resection in Males

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The new technology of robotic surgery system, as an emerging technology, has shown certain application prospects in breast surgery. However, the new technology of robotic surgery system in China in the treatment of gynecomastia is still in the exploratory stage and needs to be further improved. This prospective, single-center, single-arm clinical study was conducted to use the single-port robot and evaluate the effectiveness and safety of the subcutaneous gland resection in the treatment of gynecomastia.
Trial Details
NCT Number NCT07353411
Lead Sponsor The First Affiliated Hospital with Nanjing Medical University
Conditions Gynecomastia
Enrollment 20 participants
Start Date 2026-01-01
Primary Completion 2027-11-30 (estimated)
Study Completion 2028-11-30 (estimated)
Updated on ClinicalTrials.gov 2026-01-20